Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated threshold for thyrotropin suppression in congenital hypothyroidism

R M Schultz, M S Glassman, M H MacGillivray

    American Journal of Diseases of Children (1960)
    |January 1, 1980
    PubMed
    Summary

    Congenital hypothyroidism treatment in infants may require monitoring beyond serum thyrotropin (TSH) levels. Some infants show high TSH despite adequate thyroxine doses, indicating a need for broader assessment of thyroid hormone replacement effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: Specificity versus compensation.

    Cell death and differentiation·2016
    Same author

    BRD4 regulates Nanog expression in mouse embryonic stem cells and preimplantation embryos.

    Cell death and differentiation·2014
    Same author

    Behavior problems of handicapped adolescent female students.

    Journal of youth and adolescence·2013
    Same author

    Behavior problems of handicapped adolescent female students.

    Journal of youth and adolescence·2013
    Same author

    Biochemical studies of mammalian oogenesis: metabolic cooperativity between granulosa cells and growing mouse oocytes.

    Developmental biology·2010
    Same author

    Salmon poisoning disease in dogs: 29 cases.

    Journal of veterinary internal medicine·2010

    Area of Science:

    • Pediatric Endocrinology
    • Neonatal Care
    • Thyroid Disorders

    Background:

    • Congenital hypothyroidism (CH) requires lifelong thyroid hormone replacement therapy.
    • Monitoring treatment adequacy is crucial for infant development.
    • Serum thyrotropin (TSH) is a primary marker for assessing thyroid hormone levels.

    Purpose of the Study:

    • To investigate persistently elevated serum TSH levels in infants with CH despite adequate thyroxine (T4) dosage.
    • To evaluate the reliability of serum TSH as the sole indicator of adequate thyroid hormone replacement in early CH treatment.
    • To understand the hypothalamic-pituitary response to T4 in infants with CH.

    Main Methods:

    • Retrospective analysis of five infants diagnosed with congenital hypothyroidism.

    Related Experiment Videos

  • Monitoring of serum TSH levels over a 6 to 24-month period post-thyroxine administration.
  • Assessment of thyroxine dosage adequacy based on established clinical guidelines.

    • Main Results:

    • Five infants exhibited persistently elevated serum TSH levels for 6-24 months despite receiving adequate thyroxine doses.
    • These infants demonstrated an unusually high hypothalamic-pituitary threshold for TSH suppression by thyroxine.
    • Standard TSH monitoring alone may not accurately reflect thyroid hormone sufficiency in all CH infants.

    Conclusions:

    • Serum TSH levels alone are insufficient for evaluating the adequacy of thyroid hormone replacement in infants with congenital hypothyroidism during the initial treatment phase.
    • A higher hypothalamic-pituitary threshold for TSH suppression by thyroxine may exist in some CH infants.
    • Clinical assessment and potentially other biochemical markers should complement TSH monitoring for optimal CH management.